Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (67) Arrow Down
Filter Results: (67) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (67)
    • News  (8)
    • Research  (50)
  • Faculty Publications  (36)

Show Results For

  • All HBS Web  (67)
    • News  (8)
    • Research  (50)
  • Faculty Publications  (36)
← Page 3 of 67 Results →
  • Web

Hiring Organizations

Pioneers, Inc. EduSpaze EIG Global Energy Partners EIV Capital, LLC Electronic Arts Elephant Energy Elevate Ventures Elevation Capital Eleven Software Eli Lilly & Company Elliott Investment Management L.P.... View Details
  • 07 Feb 2024
  • News

The Sound of Success

lead to others that target different forms of congenital deafness. Boston-based Akouos (Greek, for “to listen”), acquired by Eli Lilly in 2022, focuses on developing gene therapies with the potential to... View Details
  • 08 Feb 2000
  • Research & Ideas

Building Effective R&D Capabilities Abroad

Setting up a home-base-augmenting site—one designed to gather new knowledge for a company—involves certain skills. And launching a home-base-exploiting site—one established to help a company efficiently commercialize its R&D in foreign markets—involves others. The... View Details
Keywords: by Walter Kuemmerle
  • 21 Feb 2018
  • Research & Ideas

When a Competitor Abandons the Market, Should You Advance or Retreat?

SolStock In late 2016 drug maker Eli Lilly announced it would stop research on the Alzheimer's drug solanezumab after results proved disappointing over three trials. For competitors such as Biogen, Merck,... View Details
Keywords: by Rachel Layne; Pharmaceutical; Health
  • Web

Recruiting Partners - Health Care

Consultants EchoNous Edenbridge Health Ediom, LLC Edwards Lifesciences Element Science Eli Lilly & Co. Eli Lilly and Company Elite Care ElMindA... View Details
  • 25 Jun 2020
  • Blog Post

Harvard Business School Class of 2021 Student Profiles

joint Harvard/MIT life sciences incubator that connects MBA students with scientists in Harvard and MIT’s ecosystem. HOME REGION Indianapolis, IN UNDERGRAD EDUCATION DePauw University PREVIOUS EXPERIENCE Eli View Details
  • 01 Jun 2023
  • News

From Big Pharma to Startup

Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and... View Details
Keywords: April White
  • 01 Jun 2023
  • News

Cultivating Prosperity in Afghanistan

Special Forces units while serving in Afghanistan. Saffron currently sells for $2,500 per kilogram because its harvesting and processing are so labor intensive. During the summer after their first year at HBS, Miller served as a brand marketing intern for View Details
Keywords: Jennifer Gillespie
  • 22 Aug 2005
  • Research & Ideas

The Hard Work of Failure Analysis

analyzing failure benefit in two ways. First, analyzing a failed drug sometimes reveals that the drug may have a viable alternate use. For example, Pfizer's Viagra was originally designed to be a treatment for angina, a painful heart condition. Similarly, View Details
Keywords: by Amy Edmondson & Mark D. Cannon

    Randall L. Tobias

    The first outsider to run the company, Tobias is credited with orchestrating a major turnaround of Eli Lilly. Under his direction, Lilly introduced two successful drugs (Zyprexa for schizophrenia and Gemzar... View Details
    Keywords: Healthcare

      Richard D. Wood

      During Wood’s 18-year tenure as CEO, Lilly’s revenues and earnings increased every year. He is credited with generating a sevenfold increase in revenues and a tenfold increase in earnings – making Eli Lilly... View Details
      Keywords: Healthcare

        Eugene N. Beesley

        depreciation and other expenses were cut. Though his tenure as CEO was brief, Beesley’s time at the helm of Eli Lilly allowed net sales to grow from $480 million in 1968 to just under $820 million in 1972. View Details
        Keywords: Healthcare
        • 10 May 2020
        • Blog Post

        Let’s Hear it For the Moms – The Incredible Balancing Act of Student Mothers

        | Class of 2021 Little(s): Addi (5), Logan (3) Pre-HBS Industry: Corporate Finance in Healthcare Proudest Accomplishment: Surviving 2 years at HBS in a tiny apartment with crazy toddlers (!) Post-HBS Job: Corporate Finance at Eli View Details
        • Career Coach

        Jon Puz

        Development & Sales), Deloitte Consulting (Consultant, Healthcare Strategy & Operations), Internships: Merrill Lynch Healthcare Investment Banking, Eli Lilly and Company View Details
        • 01 Mar 2011
        • News

        Fixing What Ails the Drug Industry

        at the 11th HBS Health Industry Alumni Association Conference. She joined Eli Lilly CEO John Lechleiter in addressing the November 4–6 event, titled “The Future of Therapy from the Leaders Who Create It.” So... View Details
        Keywords: pharmaceutical research; Health, Social Assistance
        • 01 Aug 2017
        • First Look

        First Look at New Research and Ideas, August 1

        Transformation at Eli Lilly & Co. (A) Faced with the imminent loss of 40% of its revenues due to patent expirations, pharma giant Eli Lilly... View Details
        Keywords: Sean Silverthorne
        • 08 Dec 2003
        • Research & Ideas

        Why Europe Lags in Pharmaceuticals and Biotech

        Bastianelli said. Also missing are the partnerships between academic and business communities that are common in the States, added Thomas G. Wellner, executive director of marketing at Eli Lilly and... View Details
        Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
        • 24 Mar 2020
        • Research & Ideas

        These Coronavirus Heroes Show Us How Crisis Leadership Works

        for COVID-19 and is currently able to run 1,000 tests per day. David A. Ricks, CEO of Eli Lilly. Under Ricks’ guidance, Lilly has teamed with AbCellera Biologics to find antibodies to disarm COVID-19.... View Details
        Keywords: by Bill George; Health
        • 29 May 2001
        • Research & Ideas

        Genomics: Can We Start Making Money Now?

        Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate... View Details
        Keywords: by Sean Silverthorne
        • 29 Jun 2022
        • Blog Post

        Harvard Business School Announces the 2022-2023 Blavatnik Fellows

        medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin Wolfe, PhD. Hunter became... View Details
        • ←
        • 1
        • 2
        • 3
        • 4
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.